Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2003
Sensitive method of detecting myocardial ischemia during dobutamine stress echocardiographySatoshi Yamada, Taisei Mikami, Kaoru Komuro, et al.
Japanese Heart Journal|May 25, 2002
Iodine-123-metaiodobenzylguanidine scintigraphy of total cardiac adrenergic denervation in Brugada syndromeNaotsugu Oyama, Noriko Oyama, Hisashi Yokoshiki, et al.
British Journal of Pharmacology|January 19, 2005
Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomySatoshi Nawate, Mitsuhiro Fukao, Ichiro Sakuma, et al.
Heart (British Cardiac Society)|November 7, 2006
Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide studyAli Nasermoaddeli, Katsuyuki Miura, Akira Matsumori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2003
Serial changes in BMIPP uptake in relation to thallium uptake in the rat myocardium after ischaemiaKazuyuki Noriyasu, Megumi Mabuchi, Yuji Kuge, et al.
Molecular and Cellular Biochemistry|May 6, 2004
Pure pressure stress increased monocarboxylate transporter in human aortic smooth muscle cell membraneKoji Oikawa, Kenji Iizuka, Takeshi Murakami, et al.
Biological & Pharmaceutical Bulletin|March 3, 2007
Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysisYoh Takekuma, Toru Takenaka, Masami Kiyokawa, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 20, 2006
Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilolYoh Takekuma, Toru Takenaka, Masami Kiyokawa, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2003
A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expressionNan Jia, Hiroshi Okamoto, Toshihiro Shimizu, et al.
Thrombosis Journal|November 14, 2003
Induction of Tissue Factor Expression in Endothelial Cells by Basic Fibroblast Growth Factor and its Modulation by Fenofibric acidTakeaki Kaneko, Satoshi Fujii, Akio Matsumoto, et al.
Pageof 13